19:27 , Sep 28, 2018 |  BC Week In Review  |  Company News

Agilent acquires tools company Acea to expand China footprint

Agilent Technologies Inc. (NYSE:A) acquired cell analysis tools company Acea Biosciences Inc. (San Diego, Calif.) for $250 million. Agilent said the acquisition will expand the company's capabilities in China, where Acea has a large manufacturing...
03:08 , Feb 3, 2016 |  BC Extra  |  Financial News

Qiming closes Fund V at $648 million

Qiming Venture Partners closed its Qiming V fund at $648 million. As with past funds, Qiming will invest Fund V in Chinese healthcare, IT, cleantech, internet and consumer companies, with more than 50% of its...
08:00 , Nov 16, 2015 |  BC Week In Review  |  Financial News

Acea Biosciences completes venture financing

Acea Biosciences Inc. , San Diego, Calif.   Business: Supply/Service, Cancer, Autoimmune   Date completed: 2015-11-06   Type: Venture financing   Raised: $30 million   Investors: Lilly Asia Ventures; Qiming Venture Partners  ...
07:00 , Oct 11, 2010 |  BC Week In Review  |  Company News

Acea Biosciences, Vivo Biosciences deal

Acea and Vivo partnered to develop label-free, real-time cell-based assays for Acea's xCELLigence system. The new assays will use Vivo's HuBiogel technology, a human-derived biomatrix system which allows for growth, proliferation and differentiation of primary,...
07:00 , Oct 4, 2010 |  BC Week In Review  |  Company News

Acea Biosciences, Cellular Dynamics, Roche deal

The companies combined CDI's iCell Cardiomyocytes with ACEA's and Roche's xCELLigence RTCA System to develop a tool to evaluate the potential cardiotoxic effects of new and previously marketed cardiac compounds. The tool is in beta...